Research programme: hepatocyte growth factor-related proteins - Dompe

Drug Profile

Research programme: hepatocyte growth factor-related proteins - Dompe

Alternative Names: Metron F1

Latest Information Update: 01 Sep 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dompe Farmaceutici
  • Class Recombinant proteins
  • Mechanism of Action Hepatocyte growth factor stimulants; Macrophage colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Alopecia; Stomatitis

Most Recent Events

  • 05 Mar 2007 Preclinical development is ongoing
  • 15 Dec 2004 This compound is still in active development
  • 09 Sep 1997 Preclinical development for Chemoprotection in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top